UCI closes salbutamol case against Chris Froome

Chris Froome (Team Sky) lost more time on stage 9 of the 2018 to Gran Sasso d'Italia

The UCI has announced that it has closed its anti-doping proceedings against Chris Froome just five days before the start of this year's Tour de France. The Team Sky rider returned an anti-doping sample with twice the permitted level of salbutamol at the 2017 Vuelta a Espana, but the UCI has said that the results do not constitute an adverse analytical finding (AAF). “In light of WADA’s unparalleled access to information and authorship of the salbutamol regime, the UCI has decided, based on WADA’s position, to close the proceedings against Mr Froome,” read the UCI statement on Monday morning. “Whilst the UCI would have obviously preferred the proceedings to have been finalised earlier in the season, it had to ensure that Mr Froome had a fair process, as it would have done with any other rider, and that the correct decision was issued. Having received WADA’s position on 28 June ...

Read on Cycling News


More Like This

Card image cap

WADA decides against Froome anti-doping appeal

View
Card image cap

UCI responds to criticism surrounding Chris Froome judgement

View
Card image cap

Chris Froome: Salbutamol case decision 'is a big moment for cycling'

View
Card image cap

Clearing Chris Froome lacks credibility without providing evidence, says anti-doping expert

View
Card image cap

UCI drops investigation into Froome, says it accepts no rules were broken in Salbutamol case

View
Card image cap

UCI says no reasoned decision will be released for Froome case, elaborates on related topics

View
Card image cap

Chris Froome cleared of doping charges and free to race Tour de France

View
Card image cap

Analysis: WADA appears to contradict UCI over Froome case decision

View
Card image cap

MPCC slams WADA over Chris Froome case, tramadol, Operacion Puerto

View
Card image cap

Lappartient says UCI had to follow WADA’s lead and clear Froome

View